Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Ryan Tunis

Cantor Fitzgerald · covers Financial Services

Period: Reporting periods mapped to calendar 2025 Q2 – 2026 Q2 (5 quarters).

Questions
30on tracked calls
Challenge rate
10%3 of 30 questions
Companies
10questioned at least once
Reporting periods
5with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 30 of 30 questions from 10 companies

TRVThe Travelers Companies, Inc.6 questions · 4 reporting periods · 0 of 6 challenging
TRV company page →

Calendar 2026 Q2

what's kind of the bottom line on the reserve review this quarter?

CreditGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Dan sized the Business Insurance drivers at a little more than $200 million from comp and around $80 million from commercial property, and said other lines netted favorable.

just looking for a little bit of an update on what you're seeing in terms of frequency and severity

Cost PressureMarginTranscript · FY2026 Q2 →
Show response

Michael credited vehicle safety technology and less measured distraction, and said there is not much evidence of driving behavior changes tied to gas prices.

Calendar 2025 Q4

Just curious how you guys are thinking about overall rate adequacy in national property headed into 2026.

Show response

Alan said national property returns are strong after many years of rate gains, so the softer pricing is not crazy given where profitability sits, though Travelers is sometimes surprised by the terms and conditions given away.

Just curious how much of that one-point deceleration is attributable to rate versus exposure?

PricingRevenue GrowthTranscript · FY2025 Q4 →
Show response

Dan said the ex-property RPC deceleration from 9% to 8% is a mix of both rate and exposure, with middle market exposure down in the webcast slides providing the rough breakout.

Calendar 2025 Q3

I'm just curious if those attritional losses have run better or worse or in line with your expectations so far

MarginMacroeconomicTranscript · FY2025 Q3 →
Show response

Dan said Q3 business insurance results were really strong with weather leaning favorable, but nothing outside the normal realm of quarter-to-quarter variability that would warrant adjusting the jump-off point.

Calendar 2025 Q2

should we think about that as having any type of formal impact on the combined expense ratio

Show response

Dan said the Canadian business is a small component of total mix with modest EPS accretion, so it shouldn't meaningfully move consolidated combined or expense ratios.

EGEverest Group5 questions · 3 reporting periods · 0 of 5 challenging
EG company page →

Calendar 2026 Q1

is there any rough rule of thumb on how we -- how you guys are thinking about growth there

Capital AllocationTranscript · FY2026 Q1 →
Show response

Kociancic guided flat to marginal AUM growth as retail reduction, premium declines, and elevated buybacks offset by reserve paydowns and investment income.

I wanted to go back to the attritional loss ratio in Global Specialty, the 58.9%

MarginCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Williamson unpacked mix shift from open market E&S casualty to specialized products like data center coverage, with smaller limits, higher attachment points, and dramatically better pricing driving conservative loss pick improvement.

Calendar 2025 Q4

should we be thinking about any drawdown of that excess as more of a '27, '28 event? Or could that potentially be

Capital AllocationGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Mark said later 2026 drawdown is on the table as the renewal rights transfer matures; buyback is the natural place to deploy unlocked capital given attractive return profile.

Calendar 2025 Q3

why do the renewal rights deal rather than pursue sale opportunities?

Capital AllocationCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Jim said transferring the back book was impractical, legal entities are shared with W&S, and AIG was the right partner for a quick, certain deal.

I'm just wondering how you're thinking about the ROE profile of this company

MarginCapital AllocationTranscript · FY2025 Q3 →
Show response

Jim said EG is still in mid-teens ROE over the cycle, potentially slightly below in 2026; rundown cost and rundown earned premium are moving in the same direction.

ACGLArch Capital Group4 questions · 2 reporting periods · 0 of 4 challenging
ACGL company page →

Calendar 2026 Q1

how should we interpret that loss ratio result this quarter in mind?

Show response

Francois explained mortgage loss ratio uptick is mechanical, newer vintage loans going into NOD are larger (post-COVID mortgage sizes). Frequency assumptions unchanged for two years. Severity per loan stable but average loan size increased. Still within expectations.

To what extent are you looking at managing the OpEx side of things as a potential source of boosting margins?

MarginCost PressureTranscript · FY2026 Q1 →
Show response

Nicolas confirmed expense management is on their mind, especially in the insurance group. Loss ratio management is more important in softening market, but expense side getting attention as well.

Calendar 2025 Q3

how much of that is, I don't know, you guys proactively walking away or a decline in exposure as opposed to rate

Competitive DynamicsRevenue GrowthTranscript · FY2025 Q3 →
Show response

Nicolas confirmed Arch is not proactively cutting back. Main drivers are E&S cedents retaining more risk and revising growth forecasts downward, reducing ceded premium. Francois emphasized the exposure drop is cedent-driven, not Arch's decision, they still like the product.

are there pockets you point out that are kind of particularly challenging to underwrite in this type of market where you really got to kind of cross your Ts and dot your Is?

Competitive DynamicsInnovation & R&DTranscript · FY2025 Q3 →
Show response

Nicolas said anti-selection risk is widespread in a competitive market. Arch's advantage is data analytics tools providing granular risk-level pricing information. Bullish about writing profitably because of these tools, would be much less bullish without them.

CBChubb Limited4 questions · 2 reporting periods · 0 of 4 challenging
CB company page →

Calendar 2025 Q4

would you actually prefer the GDP growth to be coming from more traditional means such as growth in employment

MacroeconomicDemandTranscript · FY2025 Q4 →
Show response

Evan: as citizen, broader-based growth preferred; as Chubb leader, will take adequate risk-adjusted return growth wherever it comes from, pursuing multiple directions.

the acquisition and expense ratio in North America commercial. It's kind of an upticking, I think, because of mix in middle market

MarginCost PressureTranscript · FY2025 Q4 →
Show response

Evan: Q4 impacted by fewer LPT (loss portfolio transfer) transactions, low acquisition, higher loss. Middle/small and E&S growing faster than major does push acquisition up, but not a straight line.

Calendar 2025 Q3

North America E&S, I'm guessing that's Westchester, still up 7% this quarter. You talked about a transitioning market

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Evan: property shrank intentionally; casualty, small commercial E&S digital capability, and program areas (pet insurance) drive growth. Diversification at work.

on the commercial side globally, in what ways are you seeing the macro impact your business, if at all

MacroeconomicDemandTranscript · FY2025 Q3 →
Show response

Evan: US strong but labor/payroll slowing (shows up in comp exposure adjustment), Europe slow-but-stable, Asia varies, overall no big macro impact.

AJGArthur J. Gallagher & Co.3 questions · 2 reporting periods · 2 of 3 challenging
AJG company page →

Calendar 2025 Q4

Doug, I'll put you on the spot a little bit here. Was five-eight helpful? A little bit confusing. Can you just give us an over-under in 2026 EBITDA margins

MarginGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Doug expressed confidence margins will be above the ranges provided on page 8 of the CFO commentary, citing potential synergy upside and team focus on continuous improvement. Trying to tighten disclosure ranges going forward.

Calendar 2025 Q3

it was when the last hard market was kind of in this situation, and you guys were doing 1% organic. And like what I'd say, Pat, is like you sounded like on those transcripts the same way you do now

ChallengingRevenue GrowthCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Pat explained the difference: in 2013 all lines were negative, now the renewal book still produces 3-4% organic. Additionally, 20+ years of GCOE with 16,000 people providing 500 services, Gallagher Drive data lake, and international expansion that didn't exist in 2013.

There's been a couple of quarters here, though, where we've had an investor preview, and then you've fallen a little bit light. I'm a little worried you are over worked

ChallengingGuidance ReliabilityRevenue GrowthTranscript · FY2025 Q3 →
Show response

Doug defended the forecasting: $11M miss on a $3B quarter from life sale timing (which he flagged in advance) and a $4M contingent true-up on one international program out of 600 contracts. Acknowledged the $4M got past him but noted the scale context.

HIGHartford (The)2 questions · 1 reporting period · 1 of 2 challenging
HIG company page →

Calendar 2025 Q3

case value sort of looks like any type of underlying combined ratio pressure we had in Business Insurance this quarter was in middle markets

ChallengingMarginCost PressureTranscript · FY2025 Q3 →
Show response

Chris attributed middle market UCR pressure to strong national accounts quarter with inherently higher booking ratios due to long duration. Moe added slight non-CAT property favorability was minor.

in group disability, sound like there's some paid family comp stuff. But I'm just curious if any new trends worth pointing out there

Show response

Chris explained PFML utilization increasing but pricing actions being taken on 1-2 year rate guarantees. LTD slight severity tick up from higher-salaried claims but normalizing as expected. Fish confirmed pricing increases earning into PFML book.

Show 4 more companies
LMNDLemonade, Inc.2 questions · 1 reporting period · 0 of 2 challenging
LMND company page →

Calendar 2026 Q2

it doesn't sound like to me that's coming at the expense of how you guys have been talking about growth

MarginRevenue GrowthTranscript · FY2026 Q2 →
Show response

Daniel confirmed the premise and argued the efficiency metrics are themselves the growth driver; Nick then walked expense leverage by line item.

the pet insurance gross loss ratio looked like it ticked up a little bit this quarter

Cost PressurePricingTranscript · FY2026 Q2 →
Show response

Nick named vet cost inflation as the cause, said rate is being taken to offset it, and noted the pet market still outgrows other lines.

WRBW. R. Berkley Corporation2 questions · 2 reporting periods · 0 of 2 challenging
WRB company page →

Calendar 2025 Q4

First question just on the investment fund returns, bit a bit mix. Just curious, maybe you could go into a little bit more detail there.

Capital AllocationCapex InvestmentTranscript · FY2025 Q4 →
Show response

Rob said the $32M investment fund loss was driven by a single disappointing private fund relationship and should not be the norm going forward.

Calendar 2025 Q3

just low single-digit growth in other liability. Less than I expect. I'm just curious, are you starting to see more competition

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Rob said the other liability deceleration reflects both a bit of competition and WRB's deliberate portfolio pivot based on rate, exposure, and attachment point views.

PGRProgressive Corporation1 question · 1 reporting period · 0 of 1 challenging
PGR company page →

Calendar 2025 Q3

it sounds like it's become a more insurable market. So I guess my concern would be, just like any state where you have meaningful amounts of tort reform kind of creates a lever for competition to c...

Regulation PolicyCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Tricia said Progressive's long-standing Florida #1 position and close relationships with regulators leave it well positioned even as the market attracts new entrants.

WTWWillis Towers Watson1 question · 1 reporting period · 0 of 1 challenging
WTW company page →

Calendar 2025 Q3

Can you give us some idea of geographically, how the U.S. fits in there versus International?

Revenue GrowthGeographic ExpansionTranscript · FY2025 Q3 →
Show response

Andrew declined to provide geographic detail but noted U.S. is less than half of R&B portfolio. Lucy corrected the follow-up assumption, noting particularly good performances from UK and GB/International with some outperformance there, implying U.S. may have been below segment average.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
TRV The Travelers Companies, Inc.60%none of 6 questions
EG Everest Group50%none of 5 questions
ACGL Arch Capital Group40%none of 4 questions
CB Chubb Limited40%none of 4 questions
AJG Arthur J. Gallagher & Co.367%2 of 3 questions
HIG Hartford (The)2—Rate withheld: fewer than 3 questions
LMND Lemonade, Inc.2—Rate withheld: fewer than 3 questions
WRB W. R. Berkley Corporation2—Rate withheld: fewer than 3 questions
PGR Progressive Corporation1—Rate withheld: fewer than 3 questions
WTW Willis Towers Watson1—Rate withheld: fewer than 3 questions
  • TRV
    The Travelers Companies, Inc. · 6 questions
    0%none of 6 questions
  • EG
    Everest Group · 5 questions
    0%none of 5 questions
  • ACGL
    Arch Capital Group · 4 questions
    0%none of 4 questions
  • CB
    Chubb Limited · 4 questions
    0%none of 4 questions
  • AJG
    Arthur J. Gallagher & Co. · 3 questions
    67%2 of 3 questions
  • HIG
    Hartford (The) · 2 questions
    —rate withheld: under 3 questions
  • LMND
    Lemonade, Inc. · 2 questions
    —rate withheld: under 3 questions
  • WRB
    W. R. Berkley Corporation · 2 questions
    —rate withheld: under 3 questions
  • PGR
    Progressive Corporation · 1 question
    —rate withheld: under 3 questions
  • WTW
    Willis Towers Watson · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2025 Q210%none of 1 question1
2025 Q31421%3 of 14 questions9
2025 Q470%none of 7 questions5
2026 Q140%none of 4 questions2
2026 Q240%none of 4 questions2
  1. 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q314 questions · challenge rate 21% (3 of 14 questions) · 9 companies
  3. 2025 Q47 questions · challenge rate 0% (none of 7 questions) · 5 companies
  4. 2026 Q14 questions · challenge rate 0% (none of 4 questions) · 2 companies
  5. 2026 Q24 questions · challenge rate 0% (none of 4 questions) · 2 companies

Topics

Topics tagged on this analyst’s questions.

  • Margin13
  • Revenue Growth8
  • Competitive Dynamics8
  • Cost Pressure5
  • Capital Allocation5
  • Pricing4
  • Guidance Reliability4
  • Macroeconomic3
  • Credit2
  • Demand2
Show all 15 topics
  • Capex Investment1
  • Innovation & R&D1
  • Regulation Policy1
  • Geographic Expansion1
  • M&A1